GAD - 65 Antibody (for Paraneoplastic Syndrome)

The GAD-65 Antibody Test is a specialized blood test used to detect autoantibodies against Glutamic Acid Decarboxylase-65 (GAD-65), an enzyme involved in the production of gamma-aminobutyric acid (GABA), an important neurotransmitter in the central nervous system. The presence of GAD-65 antibodies is associated with several autoimmune neurological disorders, including Stiff Person Syndrome (SPS), autoimmune cerebellar ataxia, autoimmune encephalitis, and, in some cases, paraneoplastic neurological syndromes.

Paraneoplastic syndromes are rare disorders triggered by an abnormal immune response to certain cancers. In these conditions, the immune system mistakenly attacks healthy nervous system tissue instead of targeting only cancer cells. Detecting GAD-65 antibodies can help healthcare providers investigate unexplained neurological symptoms and determine whether they are related to an autoimmune process or an underlying malignancy.

The GAD-65 Antibody Test may also be positive in some individuals with Type 1 Diabetes Mellitus or other autoimmune endocrine disorders. Therefore, test results should always be interpreted in conjunction with the patient's symptoms, medical history, neurological examination, imaging studies, and other laboratory investigations.

Doctors commonly recommend this test for patients experiencing muscle stiffness, painful muscle spasms, balance problems, coordination difficulties, seizures, memory changes, or unexplained neurological symptoms, particularly when autoimmune neurological disease or paraneoplastic syndrome is suspected.

The test is performed on a blood sample using highly sensitive immunological methods and is often ordered alongside other paraneoplastic antibody panels and autoimmune neurological investigations.

Benefits of the Test

• Detects GAD-65 autoantibodies.
• Supports the diagnosis of autoimmune neurological disorders.
• Assists in evaluating suspected paraneoplastic syndromes.
• Helps diagnose Stiff Person Syndrome.
• Useful in investigating autoimmune encephalitis and cerebellar ataxia.
• Supports early diagnosis and timely treatment.
• Requires only a simple blood sample.
• Provides valuable information for neurologists and immunologists.

Why Doctors Recommend This Test

Doctors recommend the GAD-65 Antibody Test when patients develop unexplained neurological symptoms suggestive of autoimmune disease or paraneoplastic syndrome. It is particularly useful in patients with muscle stiffness, spasms, seizures, gait instability, cerebellar symptoms, or suspected autoimmune encephalitis. The test may also be used together with imaging studies, cerebrospinal fluid (CSF) analysis, and additional autoimmune antibody panels.

Preparation Before the Test

No special preparation is required.

You may eat and drink normally unless instructed otherwise by your healthcare provider. Inform your doctor about your neurological symptoms, medications, autoimmune diseases, diabetes, or history of cancer. A blood sample is collected from a vein for laboratory analysis.

Normal Reporting Time

Typically: 5–10 Working Days

Reporting time may vary depending on laboratory methodology and reference laboratory processing.

Who Should Take This Test?

This test is recommended for:

• Individuals with unexplained muscle stiffness.
• Patients with painful muscle spasms.
• People suspected of having Stiff Person Syndrome.
• Individuals with autoimmune encephalitis.
• Patients with unexplained cerebellar ataxia.
• People with suspected paraneoplastic neurological syndromes.
• Individuals with unexplained seizures or neurological symptoms.
• Patients referred by neurologists or oncologists.
• People undergoing autoimmune neurological evaluation.
• Anyone advised by their healthcare provider.